Well some testing has been done on this subject?
http://www.jprasurg.com/article/S1748-6815(12)00318-X/pdf
Summary
Background
Soft tissue deficits associated with exposed tendon and absent paratenon pose difficult reconstructive problems due to tendon adhesions, poor range of motion, poor cosmesis, and donor site morbidity.
So it certainly can be a problem one would think?
So I am still thinking that Polynovo were delighted with their results, and I still believe that the results may be because the Novosorb is inert and doesn't support any growth? either bacterial or any other?
Well some testing has been done on this subject?...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.54 |
Change
0.110(4.53%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $2.46 | $2.57 | $2.46 | $3.283M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5750 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 3040 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |